Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Dr. Patrick Lu Intradigm Corporation, USA1 Talk
Patrick Lu is the co-founder and Executive Vice President of Intradigm Corporation. He has more than 20 years experience including 12 years of pharmaceutical industry experience in nucleic acid therapeutics, cancer drug development and cancer molecular diagnosis. At Intradigm, Dr. Lu has led efforts to build the in vivo RNAi... read moredelivery technology for both drug discovery and therapeutic development. Dr. Lu has published more than 40 articles and book chapters and holds 18 issued and pending patents. Dr. Lu has held positions at Novartis, Digene Corporation and BioReliance, Inc. Dr. Lu received his PhD from Sun Yat-sen University, China and completed his postdoctoral work at the University of Maryland at College Park and Georgetown University in 1992. A recent paper published by Dr. Lu and colleagues on the use of siRNA therapeutics to treat SARS in a monkey model has been named one of the Top 100 Science Stories of 2005 by Discover magazine.